Impact of Living Donor Liver Transplantation on COVID-19 Clinical Outcomes from a Quaternary Care Centre in Delhi
Open Access
- 12 October 2021
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 10 (4), 770-777
- https://doi.org/10.14218/jcth.2021.00303
Abstract
The anticipated fear of serious outcomes in coronavirus infected liver transplant recipients led to disruption of transplant services globally. The aim of our study was to analyze COVID-19 severity in transplant recipients and to compare the difference of COVID-19 clinical outcomes in early (1 year) post-transplant period.Keywords
This publication has 24 references indexed in Scilit:
- COVID-19 in Liver Transplant Recipients: An Initial Experience From the US EpicenterGastroenterology, 2020
- Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort studyThe Lancet, 2020
- Resuming liver transplantation amid the COVID-19 pandemicThe Lancet Gastroenterology & Hepatology, 2020
- COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in LombardyThe Lancet Gastroenterology & Hepatology, 2020
- Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI)Hepatology International, 2020
- Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infectionEClinicalMedicine, 2020
- Perioperative Presentation of COVID‐19 Disease in a Liver Transplant RecipientJournal of Hepatology, 2020
- Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevanceJournal of Hepatology, 2014
- Suppression of Coronavirus Replication by Cyclophilin InhibitorsViruses, 2013